122 related articles for article (PubMed ID: 971548)
1. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients.
Verde G; Oppizzi G; Colussi G; Cremascoli G; Botalla L; Müller EE; Silvestrini F; Chiodini PG; Liuzzi A
Clin Endocrinol (Oxf); 1976 Jul; 5(4):419-23. PubMed ID: 971548
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
3. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
Shi YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):168-72. PubMed ID: 2150352
[TBL] [Abstract][Full Text] [Related]
6. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
8. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
[TBL] [Abstract][Full Text] [Related]
9. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
[TBL] [Abstract][Full Text] [Related]
10. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
Hanew K; Aida M; Tano T; Yoshinaga K
Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
Dunn PJ; Donald RA; Espiner EA
Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
13. Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.
Giustina A; Schettino M; Bodini C; Doga M; Licini M; Giustina G
Metabolism; 1992 Dec; 41(12):1291-4. PubMed ID: 1281259
[TBL] [Abstract][Full Text] [Related]
14. Plasma growth hormone responses to sulpiride in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
[TBL] [Abstract][Full Text] [Related]
15. Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
Ferrari C; Romussi M; Benco R; Rampini P; Mailland F
Acta Endocrinol (Copenh); 1983 May; 103(1):1-6. PubMed ID: 6407250
[No Abstract] [Full Text] [Related]
16. Dopaminergic inhibition of growth hormone and prolactin release during continuous in vitro perifusion of normal and adenomatous human pituitary.
Lawton NF; Evans AJ; Weller RO
J Neurol Sci; 1981 Feb; 49(2):229-39. PubMed ID: 7217982
[TBL] [Abstract][Full Text] [Related]
17. Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegaly.
Oppizzi G; Botalla L; Verde G; Cozzi R; Liuzzi A; Chiodini PG
J Clin Endocrinol Metab; 1980 Sep; 51(3):616-9. PubMed ID: 6106023
[TBL] [Abstract][Full Text] [Related]
18. [Suppression by dopamine of GH release induced by GRF in a case of acromegaly].
Matsubara M; Odagaki E; Morioka T
Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):193-7. PubMed ID: 3111898
[TBL] [Abstract][Full Text] [Related]
19. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in women.
Ferrari C; Caldara R; Barbieri C; Testori GP; Benco R; Trezzi R; Crossignani RM; Rampini P
Neuroendocrinology; 1981 Apr; 32(4):213-6. PubMed ID: 7219673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
